ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

NCI director creates four new deputy director positions to manage the Institute.

February 20, 2004

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975